LIVZON PHARMAC. GRP H YC1 Capital Reinvestment Ratio
LIVZON PHARMAC. GRP H YC1 capital reinvestment ratio. LIVZON PHARMAC. GRP H YC1 (LP6) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (€3.15 Billion) in capital expenditures (€574.14 Million). Check LIVZON PHARMAC. GRP H YC1 (LP6) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of LIVZON PHARMAC. GRP H YC1 (2021–2025)
Capital reinvestment ratio of LIVZON PHARMAC. GRP H YC1 from 2021 to 2025. This chart tracks LIVZON PHARMAC. GRP H YC1's Capital Reinvestment Ratio across 5 annual periods. Also explore LIVZON PHARMAC. GRP H YC1 net asset momentum to track the company's year-over-year net asset growth rate.
LIVZON PHARMAC. GRP H YC1 Capital Reinvestment Ratio by Year (2021–2025)
LIVZON PHARMAC. GRP H YC1 capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of LIVZON PHARMAC. GRP H YC1.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | €3.15 Billion | €574.14 Million | ▼ -4.6% |
| 2024 | 0.19x | €2.98 Billion | €570.16 Million | ▼ -24.2% |
| 2023 | 0.25x | €3.25 Billion | €820.45 Million | ▼ -25.5% |
| 2022 | 0.34x | €2.77 Billion | €940.15 Million | ▼ -50.7% |
| 2021 | 0.69x | €1.90 Billion | €1.31 Billion | — |